- Home
- ESQ vs PCRX Comparison
ESQ vs PCRX Comparison
Compare ESQ & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- PCRX
- Stock Information
- Founded
- ESQ 2006
- PCRX 2006
- Country
- ESQ United States
- PCRX United States
- Employees
- ESQ N/A
- PCRX N/A
- Industry
- ESQ Commercial Banks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESQ Finance
- PCRX Health Care
- Exchange
- ESQ Nasdaq
- PCRX Nasdaq
- Market Cap
- ESQ 638.2M
- PCRX 1.2B
- IPO Year
- ESQ 2017
- PCRX 2011
- Fundamental
- Price
- ESQ $85.68
- PCRX $26.59
- Analyst Decision
- ESQ Hold
- PCRX Buy
- Analyst Count
- ESQ 3
- PCRX 10
- Target Price
- ESQ $88.00
- PCRX $29.30
- AVG Volume (30 Days)
- ESQ 113.9K
- PCRX 892.8K
- Earning Date
- ESQ 01-23-2025
- PCRX 02-27-2025
- Dividend Yield
- ESQ 0.81%
- PCRX N/A
- EPS Growth
- ESQ 4.68
- PCRX N/A
- EPS
- ESQ 5.14
- PCRX N/A
- Revenue
- ESQ $120,124,000.00
- PCRX $694,957,000.00
- Revenue This Year
- ESQ N/A
- PCRX $5.14
- Revenue Next Year
- ESQ $10.75
- PCRX $2.44
- P/E Ratio
- ESQ $16.70
- PCRX N/A
- Revenue Growth
- ESQ 10.21
- PCRX 4.40
- 52 Week Low
- ESQ $44.45
- PCRX $11.16
- 52 Week High
- ESQ $90.18
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- ESQ 55.86
- PCRX 77.75
- Support Level
- ESQ $81.10
- PCRX $25.06
- Resistance Level
- ESQ $90.18
- PCRX $27.10
- Average True Range (ATR)
- ESQ 2.94
- PCRX 1.45
- MACD
- ESQ 0.09
- PCRX 0.28
- Stochastic Oscillator
- ESQ 60.95
- PCRX 86.23
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.